Incannex Healthcare Inc ADR IXHL

$3.21 0.00 (—)

Valuation

Market cap
40,269,000
Revenue TTM
$0
Net income TTM
$-19,300,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
29,900
Avg volume
89,722
Day's range
$3.15 – $3.23
Shares out
12,545,000
Stochastic %K
20%
Beta
6.97
Analysts
Hold
Price target
$18.00

Price

Company profile

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treat...

Show more

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Phone
61 4 0984 0786
Website
https://www.incannex.com
Address
Rialto South Tower Level 23, 525 Collins Street Norwest, Melbourne, Australia

Latest news

Stocktwits

Stock_Catcher Oct 6, 1:57 AM
Money Tuesday Range to Run $GNS $IXHL $DVLT $BATL $DFLI
0 replies
Threescompany Oct 6, 1:52 AM
$IXHL bag holder for sure
1 replies
RogueFF7 Oct 5, 11:34 PM
$IXHL at 3.18 Incannex Market Cap is trading at half their cash balance. Crazy times.
1 replies
luklyz Oct 5, 10:24 PM
$IXHL so what are your thoughts on $APMD and their fda application for OSA where they use aroxybutynin as main ingredient same as IXHL. I think this will affect this stock in a bad way. Anyone knows more about that?
4 replies
D_Ko Oct 5, 9:17 PM
$IXHL the bulls claim they bought the bottom at $ 2.50. rode it too $5 and they didn't sell. (Idiots) They will sell soon when we are under $2.50.
0 replies
malibu_rum67 Oct 5, 9:02 PM
$IXHL … https://x.com/tomangell/status/2107128348455444813?s=46&t=GFt0KuOKtdMMdzI6inWphQ
0 replies
malibu_rum67 Oct 5, 8:32 PM
$IXHL … Angels 👼 Are Guarding This Price Point 😃!!!
0 replies
Bullish449 Oct 5, 8:20 PM
$IXHL lowest vol for 2026?
1 replies